Adaptimmune’s therapy to treat rare form of cancer gets USFDA nod
UK-based biopharmaceutical company, Adaptimmune Therapeutics Plc, got FDA approval for its cell therapy for treating a rare form of cancer.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
UK-based biopharmaceutical company, Adaptimmune Therapeutics Plc, got FDA approval for its cell therapy for treating a rare form of cancer.
HQ Team August 10, 2023: A gold-plated nanoscale tattoo-like electronics array can be inserted into live human cells, that in the future can.
Scientists develop cell therapy that when injected in the inflamed joints reduces pain and repairs cartilage
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.